NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live Lipocine Inc. Share Price Chart

O H L

Lipocine Inc. Performance Overview

Days Range
$2.15Low
$2.20High

Markets Today

Previous Close$2.22
Open$2.15
Volume43,866
Day's Range$2.15 - $2.20
52W Range$1.81 - $12.37
Market Cap$17.81 M

Historical Performance

1M Returns+8.82
3M Returns-4.72
6M Returns-69.59
1Y Returns-21.00
5Y Returns-88.74
10Y Returns-96.21

Lipocine Inc. Fundamentals

Market Cap$17.81 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$1.98 M
ROE TTM-0.54
EPS TTM$-1.87
Quarterly Earnings Growth YOYN/A
PB Ratio0.82
EBITDA$-10.31 M
Profit Margin-487.06
Market Cap$17.81 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$1.98 M
ROE TTM-0.54
EPS TTM$-1.87
Quarterly Earnings Growth YOYN/A
PB Ratio0.82
EBITDA$-10.31 M
Profit Margin-487.06

Lipocine Inc. Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$0$500.00 K$114.57 K$1.15 M$0$0
Gross Profit +$0$500.00 K$114.57 K$1.15 M$0$0
Operating Income -$2.18 M-$2.53 M-$3.36 M-$2.52 M-$3.97 M-$3.03 M
EBITDA -$2.17 M-$2.51 M-$3.35 M-$2.50 M-$3.95 M-$3.02 M
Interest Expense $0$0$0$0$0$0
Depreciation $15.57 K$16.11 K$14.12 K$14.98 K$14.81 K$14.65 K
Income Before Tax -$1.86 M-$2.21 M-$3.19 M-$2.37 M-$3.67 M-$2.62 M
Income Tax Expense $200$0$0$0$0$200
Net Income +-$1.86 M-$2.21 M-$3.19 M-$2.37 M-$3.67 M-$2.62 M
Net Profit Margin --441.14%-2781.46%-206.92%--

Lipocine Inc. Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $8.86 K$8.87 K$8.87 K$8.94 K$9.08 K$9.15 K
Reserve & Surplus -$201.63 M-$203.84 M-$207.02 M-$209.39 M-$213.08 M-$215.70 M
Non-Current Liabilities $0$0$0$0$0$0
Current Liabilities $1.30 M$1.45 M$1.93 M$2.53 M$2.53 M$2.07 M
Total Liabilities $1.30 M$1.45 M$1.93 M$2.53 M$2.53 M$2.07 M
Fixed Assets $149.50 K$133.40 K$119.27 K$104.29 K$89.48 K$74.83 K
Current Assets $20.33 M$18.42 M$15.93 M$16.88 M$25.24 M$23.74 M
Total Assets $20.50 M$18.58 M$16.07 M$17.01 M$25.36 M$23.84 M

Lipocine Inc. Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income -$1.86 M-$2.21 M-$3.19 M-$2.37 M-$3.67 M-$2.62 M
Operating Cash Flow -$1.97 M-$1.89 M-$2.99 M-$2.92 M-$2.26 M-$3.03 M
Investing Cash Flow -$882.07 K$4.50 M$701.45 K$1.57 M-$9.90 M$1.48 M
Financing Cash Flow $0$75.62 K$141.33 K$2.65 M$11.97 M$1.51 M
Change in Cash -$2.85 M$2.69 M-$2.14 M$1.30 M-$190.23 K-$36.18 K

Lipocine Inc. Return Calculator

The Lipocine Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$1,090
Invested Amount$10,000
Est. Returns$-8,910
Invest in USA Stock Today

About Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates, or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy (TRT). It also has other products in the pipeline, such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

FAQs

Lipocine Inc. (LPCN) share price as of September 18, 2026 is $2.15. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Lipocine Inc. (LPCN) Share by opening an international trading account with Angel One.
Purchasing Lipocine Inc. (LPCN) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Lipocine Inc. (LPCN) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Lipocine Inc. (LPCN) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Lipocine Inc. on September 18, 2026, is $17.81 M.
Lipocine Inc. operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Lipocine Inc. (LPCN) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91